Skip to content
Collaborators Login
  • Home
  • Who We Are
    • About Us
  • What We Do
    • Programs & Services
  • BioIntelligence
  • News
    • Press Releases
    • Publications
    • Events
  • Contact Us

Aguero C, Dhaynaut M, Normandin MD, et al. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019; 7(1):37. Doi: 10.1186/s40478-019-0686-6.

https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-019-0686-6

Post navigation

Previous: Devanand DP, Andrews H, Kreisl WC, et al. Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: Protocol for a randomized, double-blind, placebo-controlled, treatment trial. BMJ Open. 2020; 10(2):e032112. Doi: 10.1136/bmjopen-2019-032112.
Next: Zou J, Tao S, Johnson A, et al. Microglial activation, but not tau pathology, is independently associated with amyloid positivity and memory impairment. Neurobiol Aging. 2020; 85:11-21. Doi: 10.1016/j.neurobiolaging.2019.09.019.

Recent Posts

  • Enigma Biomedical – USA Announces Collaboration with Alamar Biosciences to Advance the Field of Diagnostics for Neurodegenerative Diseases
  • Enigma Biomedical USA Announces Formation of Scientific Advisory Board
  • Enigma Biomedical USA and the University of Wisconsin
  • Enigma Biomedical USA, Inc. Announces a Collaboration to Apply Novel 4R PET Imaging Biomarkers to CTE Research

Recent Comments

    Archives

    • February 2026

    Categories

    • PRESS RELEASE

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    308 N. Peters Road Suite #201
    Knoxville, TN 37922

    customercare@enigmabiomedicalgroup.com

    © Copyright 2026 Enigma Biomedical Inc. All Rights Reserved.

    • Home
    • Who We Are
      • About Us
    • What We Do
      • Programs & Services
    • BioIntelligence
    • News
      • Press Releases
      • Publications
      • Events
    • Contact Us